DC-SIGN and DC-SIGNR Bind Ebola Glycoproteins and Enhance Infection of Macrophages and Endothelial Cells

Ebola virus exhibits a broad cellular tropism in vitro. In humans and animal models, virus is found in most tissues and organs during the latter stages of infection. In contrast, a more restricted cell and tissue tropism is exhibited early in infection where macrophages, liver, lymph node, and splee...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Virology (New York, N.Y.) Ročník 305; číslo 1; s. 115 - 123
Hlavní autoři: Simmons, Graham, Reeves, Jacqueline D., Grogan, Case C., Vandenberghe, Luk H., Baribaud, Frédéric, Whitbeck, J.Charles, Burke, Emily, Buchmeier, Michael J., Soilleux, Elizabeth J., Riley, James L., Doms, Robert W., Bates, Paul, Pöhlmann, Stefan
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States Elsevier Inc 05.01.2003
Témata:
ISSN:0042-6822, 1096-0341
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Ebola virus exhibits a broad cellular tropism in vitro. In humans and animal models, virus is found in most tissues and organs during the latter stages of infection. In contrast, a more restricted cell and tissue tropism is exhibited early in infection where macrophages, liver, lymph node, and spleen are major initial targets. This indicates that cellular factors other than the broadly expressed virus receptor(s) modulate Ebola virus tropism. Here we demonstrate that the C-type lectins DC-SIGN and DC-SIGNR avidly bind Ebola glycoproteins and greatly enhance transduction of primary cells by Ebola virus pseudotypes and infection by replication-competent Ebola virus. DC-SIGN and DC-SIGNR are expressed in several early targets for Ebola virus infection, including dendritic cells, alveolar macrophages, and sinusoidal endothelial cells in the liver and lymph node. While DC-SIGN and DC-SIGNR do not directly mediate Ebola virus entry, their pattern of expression in vivo and their ability to efficiently capture virus and to enhance infection indicate that these attachment factors can play an important role in Ebola transmission, tissue tropism, and pathogenesis.
AbstractList Ebola virus exhibits a broad cellular tropism in vitro. In humans and animal models, virus is found in most tissues and organs during the latter stages of infection. In contrast, a more restricted cell and tissue tropism is exhibited early in infection where macrophages, liver, lymph node, and spleen are major initial targets. This indicates that cellular factors other than the broadly expressed virus receptor(s) modulate Ebola virus tropism. Here we demonstrate that the C-type lectins DC-SIGN and DC-SIGNR avidly bind Ebola glycoproteins and greatly enhance transduction of primary cells by Ebola virus pseudotypes and infection by replication-competent Ebola virus. DC-SIGN and DC-SIGNR are expressed in several early targets for Ebola virus infection, including dendritic cells, alveolar macrophages, and sinusoidal endothelial cells in the liver and lymph node. While DC-SIGN and DC-SIGNR do not directly mediate Ebola virus entry, their pattern of expression in vivo and their ability to efficiently capture virus and to enhance infection indicate that these attachment factors can play an important role in Ebola transmission, tissue tropism, and pathogenesis.
Ebola virus exhibits a broad cellular tropism in vitro. In humans and animal models, virus is found in most tissues and organs during the latter stages of infection. In contrast, a more restricted cell and tissue tropism is exhibited early in infection where macrophages, liver, lymph node, and spleen are major initial targets. This indicates that cellular factors other than the broadly expressed virus receptor(s) modulate Ebola virus tropism. Here we demonstrate that the C-type lectins DC-SIGN and DC-SIGNR avidly bind Ebola glycoproteins and greatly enhance transduction of primary cells by Ebola virus pseudotypes and infection by replication-competent Ebola virus. DC-SIGN and DC-SIGNR are expressed in several early targets for Ebola virus infection, including dendritic cells, alveolar macrophages, and sinusoidal endothelial cells in the liver and lymph node. While DC-SIGN and DC-SIGNR do not directly mediate Ebola virus entry, their pattern of expression in vivo and their ability to efficiently capture virus and to enhance infection indicate that these attachment factors can play an important role in Ebola transmission, tissue tropism, and pathogenesis.Ebola virus exhibits a broad cellular tropism in vitro. In humans and animal models, virus is found in most tissues and organs during the latter stages of infection. In contrast, a more restricted cell and tissue tropism is exhibited early in infection where macrophages, liver, lymph node, and spleen are major initial targets. This indicates that cellular factors other than the broadly expressed virus receptor(s) modulate Ebola virus tropism. Here we demonstrate that the C-type lectins DC-SIGN and DC-SIGNR avidly bind Ebola glycoproteins and greatly enhance transduction of primary cells by Ebola virus pseudotypes and infection by replication-competent Ebola virus. DC-SIGN and DC-SIGNR are expressed in several early targets for Ebola virus infection, including dendritic cells, alveolar macrophages, and sinusoidal endothelial cells in the liver and lymph node. While DC-SIGN and DC-SIGNR do not directly mediate Ebola virus entry, their pattern of expression in vivo and their ability to efficiently capture virus and to enhance infection indicate that these attachment factors can play an important role in Ebola transmission, tissue tropism, and pathogenesis.
Author Riley, James L.
Simmons, Graham
Burke, Emily
Reeves, Jacqueline D.
Grogan, Case C.
Buchmeier, Michael J.
Baribaud, Frédéric
Soilleux, Elizabeth J.
Vandenberghe, Luk H.
Bates, Paul
Doms, Robert W.
Whitbeck, J.Charles
Pöhlmann, Stefan
Author_xml – sequence: 1
  givenname: Graham
  surname: Simmons
  fullname: Simmons, Graham
  organization: Department of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania, 19104
– sequence: 2
  givenname: Jacqueline D.
  surname: Reeves
  fullname: Reeves, Jacqueline D.
  organization: Department of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania, 19104
– sequence: 3
  givenname: Case C.
  surname: Grogan
  fullname: Grogan, Case C.
  organization: USAMRIID, Ft. Detrick, Frederick, Maryland, 21702
– sequence: 4
  givenname: Luk H.
  surname: Vandenberghe
  fullname: Vandenberghe, Luk H.
  organization: Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania, 19104
– sequence: 5
  givenname: Frédéric
  surname: Baribaud
  fullname: Baribaud, Frédéric
  organization: Department of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania, 19104
– sequence: 6
  givenname: J.Charles
  surname: Whitbeck
  fullname: Whitbeck, J.Charles
  organization: School of Dental Medicine, Department of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania, 19104
– sequence: 7
  givenname: Emily
  surname: Burke
  fullname: Burke, Emily
  organization: Division of Virology, Scripps Research Institute, La Jolla, California, 92037
– sequence: 8
  givenname: Michael J.
  surname: Buchmeier
  fullname: Buchmeier, Michael J.
  organization: Division of Virology, Scripps Research Institute, La Jolla, California, 92037
– sequence: 9
  givenname: Elizabeth J.
  surname: Soilleux
  fullname: Soilleux, Elizabeth J.
  organization: Department of Molecular Histopathology, University of Cambridge, Cambridge, CB2 1QP, United Kingdom
– sequence: 10
  givenname: James L.
  surname: Riley
  fullname: Riley, James L.
  organization: Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania, 19104
– sequence: 11
  givenname: Robert W.
  surname: Doms
  fullname: Doms, Robert W.
  organization: Department of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania, 19104
– sequence: 12
  givenname: Paul
  surname: Bates
  fullname: Bates, Paul
  organization: Department of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania, 19104
– sequence: 13
  givenname: Stefan
  surname: Pöhlmann
  fullname: Pöhlmann, Stefan
  organization: Department of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania, 19104
BackLink https://www.ncbi.nlm.nih.gov/pubmed/12504546$$D View this record in MEDLINE/PubMed
BookMark eNqFkU1vEzEQhi1URNOWK0e0J24bxh9re48QQohUQIL2bHm9XmJw7GBvKuXf421SIVUqnOyRn2c0nvcCnYUYLEKvMMwxAH9751KcEwAyx4LCMzTD0PIaKMNnaAbASM0lIefoIuefUGoh4AU6x6QB1jA-Q5sPi_r7evWl0qGvTvdv1XtXqmUXva5W_mDiLsXRupDvqWXY6GBstQ6DNaOLoYpD9VmbFHcb_cM-QH0cN9Y77auF9T5foeeD9tm-PJ2X6Pbj8mbxqb7-ulov3l3Xhkk21rQXHaeydGYgtWFdAzAIbQhlLR16IQxjhtMGTHmTgrbDYDosWkZ1-RrR9BK9OfYtM__e2zyqrcumTKCDjfusBGlJCw3_L4glp1hKXMDXJ3DfbW2vdsltdTqohyUWYH4EygpyTnb4i4CaUlJTSmpKSU0pFYE9Eowb9bTKMWnnn9bkUbNlf3fOJpWNsyWK3qWShOqje1rlj1TjXXBG-1_28C_xD1SJuck
CitedBy_id crossref_primary_10_1073_pnas_0901783106
crossref_primary_10_1016_j_micinf_2009_09_004
crossref_primary_10_1128_JVI_77_7_4070_4080_2003
crossref_primary_10_1146_annurev_genom_083115_022446
crossref_primary_10_1155_2013_487585
crossref_primary_10_3109_07388551_2015_1114465
crossref_primary_10_1128_JVI_79_8_4793_4805_2005
crossref_primary_10_1016_j_coi_2015_06_003
crossref_primary_10_1128_JVI_02202_13
crossref_primary_10_1016_j_jim_2016_05_011
crossref_primary_10_1016_j_virol_2005_11_033
crossref_primary_10_1213_ANE_0000000000000866
crossref_primary_10_1189_jlb_0807523
crossref_primary_10_1016_j_virol_2007_03_020
crossref_primary_10_1038_nrmicro3524
crossref_primary_10_1186_1743_422X_5_142
crossref_primary_10_3389_fgene_2022_883234
crossref_primary_10_1074_jbc_M609689200
crossref_primary_10_1128_JVI_01025_13
crossref_primary_10_3389_fcvm_2021_619690
crossref_primary_10_3390_v11040374
crossref_primary_10_1002_rmv_1841
crossref_primary_10_1016_j_virol_2011_04_002
crossref_primary_10_1128_JVI_02265_13
crossref_primary_10_1038_nri1182
crossref_primary_10_3390_pathogens14040323
crossref_primary_10_3390_molecules26113304
crossref_primary_10_1128_JVI_00136_06
crossref_primary_10_3390_ijms26052329
crossref_primary_10_1016_j_molimm_2004_06_015
crossref_primary_10_1016_j_virol_2005_06_026
crossref_primary_10_1128_JVI_77_24_13433_13438_2003
crossref_primary_10_1128_JVI_01157_06
crossref_primary_10_1016_j_bbrc_2010_10_136
crossref_primary_10_1093_infdis_jiv101
crossref_primary_10_1128_JVI_01598_12
crossref_primary_10_1128_JVI_00239_10
crossref_primary_10_3390_pathogens10101330
crossref_primary_10_1002_jmv_27673
crossref_primary_10_1371_journal_pone_0214968
crossref_primary_10_1016_j_virol_2011_08_009
crossref_primary_10_1038_nrd1694
crossref_primary_10_1128_JVI_80_10_4771_4780_2006
crossref_primary_10_1038_nrd_2017_251
crossref_primary_10_1371_journal_ppat_1003232
crossref_primary_10_1371_journal_pntd_0006983
crossref_primary_10_1053_j_gastro_2004_01_028
crossref_primary_10_1517_14712598_4_3_329
crossref_primary_10_1016_j_jmb_2005_01_063
crossref_primary_10_1016_j_azn_2025_04_003
crossref_primary_10_1128_JVI_02545_05
crossref_primary_10_3390_ijms221910577
crossref_primary_10_1128_JVI_00554_10
crossref_primary_10_1111_j_1600_065X_2007_00551_x
crossref_primary_10_1517_13543776_17_2_243
crossref_primary_10_3390_v11010015
crossref_primary_10_1002_rcm_4410
crossref_primary_10_1038_emboj_2012_53
crossref_primary_10_1016_j_virol_2006_04_038
crossref_primary_10_1016_j_antiviral_2012_01_011
crossref_primary_10_3390_v9030059
crossref_primary_10_1371_journal_ppat_1008900
crossref_primary_10_1038_s41579_019_0233_2
crossref_primary_10_1128_JVI_00128_13
crossref_primary_10_1016_j_virol_2009_10_028
crossref_primary_10_1016_j_cll_2006_05_001
crossref_primary_10_1002_eji_202149298
crossref_primary_10_3390_v12050571
crossref_primary_10_1128_JVI_01634_12
crossref_primary_10_1128_JVI_79_8_4589_4598_2005
crossref_primary_10_1083_jcb_201108131
crossref_primary_10_1073_pnas_2119676119
crossref_primary_10_1371_journal_pone_0149651
crossref_primary_10_3390_v4081354
crossref_primary_10_1016_j_antiviral_2017_11_016
crossref_primary_10_1002_wnan_1181
crossref_primary_10_1016_j_virol_2011_07_018
crossref_primary_10_1242_jcs_119685
crossref_primary_10_3389_fimmu_2024_1439971
crossref_primary_10_1093_infdis_jiv255
crossref_primary_10_1371_journal_pone_0179177
crossref_primary_10_1586_14760584_6_1_57
crossref_primary_10_1016_j_bbrc_2013_10_106
crossref_primary_10_1093_intimm_dxl011
crossref_primary_10_1128_JVI_02190_10
crossref_primary_10_1016_j_talanta_2021_122916
crossref_primary_10_1128_JVI_01832_09
crossref_primary_10_1111_1348_0421_13211
crossref_primary_10_1074_jbc_M601796200
crossref_primary_10_1128_JVI_00232_16
crossref_primary_10_1016_j_virol_2007_11_001
crossref_primary_10_1016_j_mam_2022_101113
crossref_primary_10_1371_journal_ppat_1006397
crossref_primary_10_3390_pathogens8040192
crossref_primary_10_1007_s10875_007_9131_x
crossref_primary_10_1007_s40475_015_0039_x
crossref_primary_10_1002_path_4456
crossref_primary_10_1093_infdis_jiv140
crossref_primary_10_1126_science_1110656
crossref_primary_10_3390_v4123336
crossref_primary_10_1128_JVI_00453_11
crossref_primary_10_1016_j_vaccine_2006_09_076
crossref_primary_10_1371_journal_pone_0160410
crossref_primary_10_1002_med_20216
crossref_primary_10_1051_medsci_2025010
crossref_primary_10_1371_journal_ppat_1009407
crossref_primary_10_3390_ijms22020743
crossref_primary_10_1074_jbc_M508801200
crossref_primary_10_1038_nri2098
crossref_primary_10_1371_journal_ppat_1001121
crossref_primary_10_1371_journal_ppat_1006139
crossref_primary_10_1016_j_virol_2019_03_020
crossref_primary_10_1189_jlb_0503231
crossref_primary_10_1128_JVI_02232_10
crossref_primary_10_1128_JVI_02628_12
crossref_primary_10_1128_JVI_06346_11
crossref_primary_10_1080_22221751_2021_1997075
crossref_primary_10_1002_cmdc_202100348
crossref_primary_10_1074_jbc_M602430200
crossref_primary_10_1080_15548627_2025_2492877
crossref_primary_10_1128_JVI_78_10_5486_5490_2004
crossref_primary_10_2217_fvl_09_56
crossref_primary_10_1128_JVI_80_3_1290_1301_2006
crossref_primary_10_1016_j_coi_2004_05_010
crossref_primary_10_1146_annurev_immunol_22_012703_104558
crossref_primary_10_1007_s11481_010_9208_9
crossref_primary_10_1128_JVI_02205_08
crossref_primary_10_3390_v11030275
crossref_primary_10_3390_v6093683
crossref_primary_10_3390_pathogens11121400
crossref_primary_10_1016_j_coviro_2012_02_015
crossref_primary_10_1016_j_virusres_2006_06_002
crossref_primary_10_3390_v11030274
crossref_primary_10_1016_j_antiviral_2016_09_001
crossref_primary_10_1128_JVI_00304_16
crossref_primary_10_4049_jimmunol_176_1_426
crossref_primary_10_1007_s00726_009_0363_3
crossref_primary_10_1038_s42003_022_03767_1
crossref_primary_10_1128_AAC_47_12_3970_3972_2003
crossref_primary_10_1080_22221751_2020_1827985
crossref_primary_10_1371_journal_ppat_1009500
crossref_primary_10_1002_eji_200939351
crossref_primary_10_1128_jvi_00499_24
crossref_primary_10_3389_fimmu_2014_00323
crossref_primary_10_1093_procel_pwac012
crossref_primary_10_1093_infdis_jiu088
crossref_primary_10_1517_17460441_2012_714364
crossref_primary_10_3389_fimmu_2025_1618650
crossref_primary_10_1111_imm_13889
crossref_primary_10_1128_JVI_01430_19
crossref_primary_10_3390_ph13080179
crossref_primary_10_1016_j_immuni_2021_01_015
crossref_primary_10_1074_jbc_M706292200
crossref_primary_10_3390_v6041654
crossref_primary_10_1016_j_placenta_2022_10_002
crossref_primary_10_1189_jlb_1011492
crossref_primary_10_5812_archneurosci_35027
crossref_primary_10_1128_JVI_01956_08
crossref_primary_10_1016_j_vetmic_2015_11_011
crossref_primary_10_3389_fcimb_2022_1023557
crossref_primary_10_1016_j_virol_2011_02_020
crossref_primary_10_1093_infdis_jiv189
crossref_primary_10_1016_j_jinf_2012_03_019
crossref_primary_10_1016_j_virusres_2014_07_003
crossref_primary_10_3389_fimmu_2022_856713
crossref_primary_10_1128_JVI_78_6_2943_2947_2004
crossref_primary_10_1016_j_cll_2006_03_006
crossref_primary_10_1016_j_jmb_2009_10_006
crossref_primary_10_1016_j_pep_2017_04_010
crossref_primary_10_1016_j_jprot_2015_03_031
crossref_primary_10_1080_15384101_2015_1068472
crossref_primary_10_1016_j_dci_2013_11_017
crossref_primary_10_1093_infdis_jiu407
crossref_primary_10_1016_S0002_9440_10_63592_4
crossref_primary_10_1128_JVI_05300_11
crossref_primary_10_1073_pnas_1019030108
crossref_primary_10_1128_JVI_78_12_6134_6142_2004
crossref_primary_10_1016_j_antiviral_2019_104567
crossref_primary_10_1128_JVI_00092_18
crossref_primary_10_1016_j_cll_2009_12_001
crossref_primary_10_1128_JVI_01893_13
crossref_primary_10_1016_j_jics_2023_100936
crossref_primary_10_1128_JVI_01488_16
crossref_primary_10_3748_wjg_v10_i7_925
crossref_primary_10_1016_S0020_7519_03_00064_X
crossref_primary_10_1086_520594
crossref_primary_10_1016_j_cellimm_2017_11_009
crossref_primary_10_1016_j_immuni_2024_03_005
crossref_primary_10_1016_j_cell_2015_12_044
crossref_primary_10_1160_TH05_03_0153
crossref_primary_10_1016_j_virol_2003_09_016
crossref_primary_10_1128_JVI_02433_06
crossref_primary_10_1139_bcb_2012_0110
crossref_primary_10_1002_jmv_20532
crossref_primary_10_3390_ijms21249644
crossref_primary_10_1038_nsmb784
crossref_primary_10_1371_journal_ppat_1012444
crossref_primary_10_2217_fvl_2016_0143
crossref_primary_10_1016_j_cell_2014_10_006
crossref_primary_10_1016_j_virol_2006_06_041
crossref_primary_10_1074_jbc_M112_380121
crossref_primary_10_3390_ijms22115676
crossref_primary_10_1371_journal_pone_0224082
crossref_primary_10_3390_vaccines9050457
crossref_primary_10_1128_JVI_77_18_9733_9737_2003
crossref_primary_10_1371_journal_pntd_0007819
crossref_primary_10_1016_j_smim_2004_02_002
crossref_primary_10_1016_j_isci_2021_102266
crossref_primary_10_1186_1471_2350_11_161
crossref_primary_10_1016_j_antiviral_2009_03_011
crossref_primary_10_3390_v13020170
crossref_primary_10_1073_pnas_0403812101
crossref_primary_10_1093_jac_dku091
crossref_primary_10_1016_j_virol_2009_07_013
crossref_primary_10_1038_s41598_021_03201_2
crossref_primary_10_1016_j_fsi_2009_06_018
crossref_primary_10_1146_annurev_immunol_25_022106_141706
crossref_primary_10_1371_journal_pone_0097695
crossref_primary_10_1016_j_virol_2016_08_005
crossref_primary_10_1111_boc_202200043
crossref_primary_10_1128_JVI_02021_09
crossref_primary_10_1093_infdis_jir295
crossref_primary_10_1128_JVI_77_22_12022_12032_2003
crossref_primary_10_1099_jgv_0_002120
crossref_primary_10_1016_j_virol_2007_07_004
crossref_primary_10_1128_JVI_03372_12
crossref_primary_10_3390_biom11111586
crossref_primary_10_1038_nrmicro2764
crossref_primary_10_1016_j_virol_2005_10_008
crossref_primary_10_1128_JVI_01456_10
crossref_primary_10_1159_000517628
crossref_primary_10_1007_s00109_008_0350_2
crossref_primary_10_1586_14760584_4_3_429
crossref_primary_10_3390_v4020258
crossref_primary_10_1086_520607
crossref_primary_10_1128_JVI_01427_14
crossref_primary_10_1038_nm1142
crossref_primary_10_3390_v13091793
crossref_primary_10_1074_jbc_M400184200
crossref_primary_10_3390_ijms21051643
crossref_primary_10_1186_1742_4690_10_48
crossref_primary_10_1016_j_antiviral_2016_01_001
crossref_primary_10_1007_s40588_015_0021_3
crossref_primary_10_1016_j_tim_2015_04_006
crossref_primary_10_1016_j_virol_2012_07_012
crossref_primary_10_1371_journal_pone_0166013
crossref_primary_10_3389_fimmu_2018_00590
crossref_primary_10_1128_JVI_00136_12
crossref_primary_10_1016_j_thromres_2006_06_006
crossref_primary_10_3390_v3081501
crossref_primary_10_1126_science_1094823
crossref_primary_10_3390_biology10010001
crossref_primary_10_1073_pnas_1721646115
crossref_primary_10_2353_ajpath_2006_051191
crossref_primary_10_1002_cbic_202000238
crossref_primary_10_1021_jacs_1c06778
crossref_primary_10_1208_s12248_009_9080_9
crossref_primary_10_1016_S1473_3099_04_01103_X
crossref_primary_10_1586_eri_12_104
crossref_primary_10_1128_JVI_78_21_12090_12095_2004
Cites_doi 10.1073/pnas.051631398
10.1128/JVI.75.10.4664-4672.2001
10.1002/jss.400070206
10.1128/JVI.76.4.1866-1875.2002
10.1074/jbc.M104565200
10.4049/jimmunol.165.6.2937
10.1128/JVI.72.11.8463-8471.1998
10.1128/JVI.76.18.9135-9142.2002
10.1016/S0092-8674(00)80694-7
10.1128/jvi.76.5.2518-2528.2002
10.1002/path.1711470308
10.1189/jlb.71.3.445
10.1073/pnas.96.9.5215
10.1093/glycob/2.4.299
10.1128/JVI.76.13.6841-6844.2002
10.1093/nar/23.4.628
10.1006/viro.1998.9218
10.1073/pnas.95.5.2509
10.1086/514319
10.1126/science.1066371
10.1046/j.1365-2249.2001.01517.x
10.1016/0042-6822(89)90287-0
10.1016/S0092-8674(01)00418-4
10.1006/viro.1995.1016
10.1128/JVI.72.4.3155-3160.1998
10.1084/jem.193.6.671
10.1128/jvi.68.8.5133-5141.1994
10.1002/jmv.2073
10.1128/JVI.74.21.10074-10080.2000
10.1128/JVI.75.21.10523-10526.2001
10.1016/S1471-4906(01)02081-6
10.1086/514293
10.1099/0022-1317-76-2-393
ContentType Journal Article
Copyright 2003 Elsevier Science (USA)
Copyright_xml – notice: 2003 Elsevier Science (USA)
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7U9
H94
7X8
DOI 10.1006/viro.2002.1730
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
Immunology Abstracts
Virology and AIDS Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE


AIDS and Cancer Research Abstracts
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1096-0341
EndPage 123
ExternalDocumentID 12504546
10_1006_viro_2002_1730
S0042682202917307
Genre Research Support, U.S. Gov't, P.H.S
Journal Article
GrantInformation_xml – fundername: PHS HHS
  grantid: R01 40880
– fundername: NIAID NIH HHS
  grantid: R01 AI43455
– fundername: NIAID NIH HHS
  grantid: R01 AI043455
– fundername: NCI NIH HHS
  grantid: CA76256
– fundername: NCI NIH HHS
  grantid: R01 CA076256
– fundername: NIAID NIH HHS
  grantid: P30-AI45008
GroupedDBID ---
--K
--M
-DZ
-~X
.GJ
.~1
123
1B1
1RT
1~.
1~5
29Q
3O-
4.4
457
4G.
53G
5RE
5VS
7-5
71M
8P~
9JM
AAAJQ
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AARKO
AATTM
AAXKI
AAXUO
ABBQC
ABFNM
ABFRF
ABJNI
ABMAC
ABUFD
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACLOT
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADFGL
ADMUD
ADNMO
ADVLN
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEXQZ
AFFNX
AFPUW
AFTJW
AFXIZ
AGEKW
AGUBO
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
AXJTR
BKOJK
BLXMC
BNPGV
CAG
CJTIS
COF
CS3
DM4
DU5
EBS
EFBJH
EFKBS
EFLBG
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FNPLU
FYGXN
G-Q
HMG
IHE
IXB
J1W
KOM
LG5
LUGTX
LZ5
M29
M41
MO0
N9A
O-L
OAUVE
OHT
OK1
OZT
P-9
P2P
PC.
Q38
Q44
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SSH
SSI
SSZ
T5K
TN5
WH7
XPP
Y6R
ZGI
ZU3
~G-
~HD
~KM
6I.
AACTN
AAFTH
AAIAV
ABLVK
ABVKL
ABYKQ
AFCTW
AFKWA
AFMIJ
AJBFU
AJOXV
AMFUW
LCYCR
NCXOZ
RIG
.1-
.55
.FO
0R~
1P~
9DU
AAQXK
AAYWO
AAYXX
ABEFU
ABMZM
AEBSH
AEVXI
AFJKZ
AFRHN
AGHFR
AGQPQ
AJUYK
APXCP
ASPBG
AVWKF
AZFZN
CITATION
EJD
FA8
FEDTE
FGOYB
G-2
GBLVA
HEJ
HMK
HMO
HVGLF
HX~
HZ~
H~9
MVM
O9-
OD-
OO.
P-8
R2-
SAE
SEW
SIN
UAP
UQL
WUQ
X7M
XOL
Z5R
ZKB
ZMT
0SF
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7U9
H94
7X8
ID FETCH-LOGICAL-c484t-3d7b638fec408ac4b500f7ac23493fd77c44c6350cc4b8739ffcb17943a7702a3
ISICitedReferencesCount 305
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000180214200012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0042-6822
IngestDate Sun Nov 09 13:09:01 EST 2025
Sun Sep 28 12:06:43 EDT 2025
Wed Feb 19 02:36:08 EST 2025
Sat Nov 29 07:30:37 EST 2025
Tue Nov 18 21:02:51 EST 2025
Fri Feb 23 02:25:10 EST 2024
Tue Oct 14 19:36:01 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License http://www.elsevier.com/open-access/userlicense/1.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c484t-3d7b638fec408ac4b500f7ac23493fd77c44c6350cc4b8739ffcb17943a7702a3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
OpenAccessLink https://dx.doi.org/10.1006/viro.2002.1730
PMID 12504546
PQID 18631881
PQPubID 23462
PageCount 9
ParticipantIDs proquest_miscellaneous_72929056
proquest_miscellaneous_18631881
pubmed_primary_12504546
crossref_primary_10_1006_viro_2002_1730
crossref_citationtrail_10_1006_viro_2002_1730
elsevier_sciencedirect_doi_10_1006_viro_2002_1730
elsevier_clinicalkey_doi_10_1006_viro_2002_1730
PublicationCentury 2000
PublicationDate 2003-01-05
PublicationDateYYYYMMDD 2003-01-05
PublicationDate_xml – month: 01
  year: 2003
  text: 2003-01-05
  day: 05
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Virology (New York, N.Y.)
PublicationTitleAlternate Virology
PublicationYear 2003
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Auperin, McCormick (RF2) 1989; 168
Pöhlmann, Soilleux, Baribaud, Leslie, Morris, Trowsdale, Lee, Coleman, Doms (RF26) 2001; 98
Lee, Sharron, Montaner, Weissman, Doms (RF19) 1999; 96
Geijtenbeek, Kwon, Torensma, van Vliet, van Duijnhoven, Middel, Cornelissen, Nottet, KewalRamani, Littman, Figdor, van Kooyk (RF12) 2000; 100
Feinberg, Mitchell, Drickamer, Weis (RF10) 2001; 294
Ryabchikova, Kolesnikova, Luchko (RF28) 1999; 179
Hutchinson, Villinger, Miranda, Ksiazek, Peters, Rollin (RF16) 2001; 65
Bashirova, Geijtenbeek, van Duijnhoven, van Vliet, Eilering, Martin, Wu, Martin, Viebig, Knolle, KewalRamani, van Kooyk, Carrington (RF4) 2001; 193
Leroy, Baize, Debre, Lansoud-Soukate, Mavoungou (RF20) 2001; 124
He, Zhou, da Costa, Yu, Kinzler, Vogelstein (RF14) 1998; 95
Soilleux, Barten, Trowsdale (RF32) 2000; 165
O'Doherty, Swiggard, Malim (RF23) 2000; 74
Warner, Geraghty, Martinez, Montgomery, Whitbeck, Xu, Eisenberg, Cohen, Spear (RF36) 1998; 246
Ryabchikova, Kolesnikova, Netesov (RF29) 1999; 235
Pöhlmann, Baribaud, Doms (RF27) 2001; 22
Wool-Lewis, Bates (RF37) 1998; 72
Pöhlmann, Baribaud, Lee, Leslie, Sanchez, Hiebenthal-Millow, Münch, Kirchhoff, Doms (RF24) 2001; 75
Pöhlmann, Leslie, Edwards, Macfarlan, Reeves, Hiebenthal-Millow, Kirchhoff, Baribaud, Doms (RF25) 2001; 75
Baribaud, Pöhlmann, Leslie, Mortari, Doms (RF3) 2002; 76
Hunt, Summers (RF15) 1977; 7
Geyer, Will, Feldmann, Klenk, Geyer (RF13) 1992; 2
Chan, Empig, Welte, Speck, Schmaljohn, Kreisberg, Goldsmith (RF7) 2001; 106
Mitchell, Fadden, Drickamer (RF22) 2001; 276
Baskerville, Fisher-Hoch, Neild, Dowsett (RF5) 1985; 147
Connor, Chen, Choe, Landau (RF8) 1995; 206
Fisher-Hoch, McCormick (RF11) 1999; 235
Jameson, Baribaud, Pöhlmann, Ghavimi, Mortari, Doms, Iwasaki (RF17) 2002; 76
Schnittler, Feldmann (RF30) 1999; 235
Soneoka, Cannon, Ramsdale, Griffiths, Romano, Kingsman, Kingsman (RF34) 1995; 23
WHO (RF35) 1978; 56
Johnson, Jaax, White, Jahrling (RF18) 1995; 76
Linder, Wenzel, Linder, Stirm (RF21) 1994; 68
Becker, Spiess, Klenk (RF6) 1995; 76
Dull, Zufferey, Kelly, Mandel, Nguyen, Trono, Naldini (RF9) 1998; 72
Zaki, Shieh, Greer, Goldsmith, Ferebee, Katshitshi, Tshioko, Bwaka, Swanepoel, Calain, Khan, Lloyd, Rollin, Ksiazek, Peters (RF38) 1999; 179
Soilleux, Morris, Leslie, Chehimi, Trowsdale, Montaner, Doms, Weissman, Coleman, Lee (RF33) 2002; 71
Alvarez, Lasala, Carrillo, Muniz, Corbi, Delgado (RF1) 2002; 76
Simmons, Wool-Lewis, Baribaud, Netter, Bates (RF31) 2002; 76
Ryabchikova (10.1006/viro.2002.1730_RF28) 1999; 179
Baribaud (10.1006/viro.2002.1730_RF3) 2002; 76
Fisher-Hoch (10.1006/viro.2002.1730_RF11) 1999; 235
Leroy (10.1006/viro.2002.1730_RF20) 2001; 124
Simmons (10.1006/viro.2002.1730_RF31) 2002; 76
Schnittler (10.1006/viro.2002.1730_RF30) 1999; 235
Becker (10.1006/viro.2002.1730_RF6) 1995; 76
Pöhlmann (10.1006/viro.2002.1730_RF25) 2001; 75
Baskerville (10.1006/viro.2002.1730_RF5) 1985; 147
He (10.1006/viro.2002.1730_RF14) 1998; 95
Soilleux (10.1006/viro.2002.1730_RF32) 2000; 165
Mitchell (10.1006/viro.2002.1730_RF22) 2001; 276
Connor (10.1006/viro.2002.1730_RF8) 1995; 206
Hunt (10.1006/viro.2002.1730_RF15) 1977; 7
Johnson (10.1006/viro.2002.1730_RF18) 1995; 76
Lee (10.1006/viro.2002.1730_RF19) 1999; 96
WHO (10.1006/viro.2002.1730_RF35) 1978; 56
Zaki (10.1006/viro.2002.1730_RF38) 1999; 179
Chan (10.1006/viro.2002.1730_RF7) 2001; 106
Geijtenbeek (10.1006/viro.2002.1730_RF12) 2000; 100
Soneoka (10.1006/viro.2002.1730_RF34) 1995; 23
Bashirova (10.1006/viro.2002.1730_RF4) 2001; 193
Feinberg (10.1006/viro.2002.1730_RF10) 2001; 294
Linder (10.1006/viro.2002.1730_RF21) 1994; 68
O'Doherty (10.1006/viro.2002.1730_RF23) 2000; 74
Pöhlmann (10.1006/viro.2002.1730_RF27) 2001; 22
Hutchinson (10.1006/viro.2002.1730_RF16) 2001; 65
Pöhlmann (10.1006/viro.2002.1730_RF26) 2001; 98
Jameson (10.1006/viro.2002.1730_RF17) 2002; 76
Pöhlmann (10.1006/viro.2002.1730_RF24) 2001; 75
Auperin (10.1006/viro.2002.1730_RF2) 1989; 168
Soilleux (10.1006/viro.2002.1730_RF33) 2002; 71
Wool-Lewis (10.1006/viro.2002.1730_RF37) 1998; 72
Dull (10.1006/viro.2002.1730_RF9) 1998; 72
Alvarez (10.1006/viro.2002.1730_RF1) 2002; 76
Geyer (10.1006/viro.2002.1730_RF13) 1992; 2
Warner (10.1006/viro.2002.1730_RF36) 1998; 246
Ryabchikova (10.1006/viro.2002.1730_RF29) 1999; 235
References_xml – volume: 235
  start-page: 175
  year: 1999
  end-page: 204
  ident: RF30
  article-title: Molecular pathogenesis of filovirus infections: Role of macrophages and endothelial cells
  publication-title: Curr. Top. Microbiol. Immunol.
– volume: 179
  start-page: S36
  year: 1999
  end-page: S47
  ident: RF38
  article-title: A novel immunohistochemical assay for the detection of Ebola virus in skin: Implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. Commission de Lutte contre les Epidemies a Kikwit
  publication-title: J. Infect. Dis.
– volume: 68
  start-page: 5133
  year: 1994
  end-page: 5141
  ident: RF21
  article-title: Structural elements in glycoprotein 70 from polytropic Friend mink cell focus-inducing virus and glycoprotein 71 from ecotropic Friend murine leukemia virus, as defined by disulfide-bonding pattern and limited proteolysis
  publication-title: J. Virol.
– volume: 22
  start-page: 643
  year: 2001
  end-page: 646
  ident: RF27
  article-title: DC-SIGN and DC-SIGNR: Helping hands for HIV
  publication-title: Trends Immunol.
– volume: 76
  start-page: 1866
  year: 2002
  end-page: 1875
  ident: RF17
  article-title: Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques
  publication-title: J. Virol.
– volume: 72
  start-page: 3155
  year: 1998
  end-page: 3160
  ident: RF37
  article-title: Characterization of Ebola virus entry by using pseudotyped viruses: Identification of receptor-deficient cell lines
  publication-title: J. Virol.
– volume: 235
  start-page: 145
  year: 1999
  end-page: 173
  ident: RF29
  article-title: Animal pathology of filoviral infections
  publication-title: Curr. Top. Microbiol. Immunol.
– volume: 23
  start-page: 628
  year: 1995
  end-page: 633
  ident: RF34
  article-title: A transient three-plasmid expression system for the production of high titer retroviral vectors
  publication-title: Nucleic Acids Res.
– volume: 294
  start-page: 2163
  year: 2001
  end-page: 2166
  ident: RF10
  article-title: Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR
  publication-title: Science
– volume: 76
  start-page: 2518
  year: 2002
  end-page: 2528
  ident: RF31
  article-title: Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence
  publication-title: J. Virol.
– volume: 75
  start-page: 4664
  year: 2001
  end-page: 4672
  ident: RF24
  article-title: DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus
  publication-title: J. Virol.
– volume: 7
  start-page: 213
  year: 1977
  end-page: 221
  ident: RF15
  article-title: Glycosylation of VSV glycoprotein is similar in cystic fibrosis, heterozygous carrier, and normal human fibroblasts
  publication-title: J. Supramol. Struct.
– volume: 106
  start-page: 117
  year: 2001
  end-page: 126
  ident: RF7
  article-title: Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses
  publication-title: Cell
– volume: 246
  start-page: 179
  year: 1998
  end-page: 189
  ident: RF36
  article-title: A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus
  publication-title: Virology
– volume: 71
  start-page: 445
  year: 2002
  end-page: 457
  ident: RF33
  article-title: Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro
  publication-title: J. Leukoc. Biol.
– volume: 100
  start-page: 587
  year: 2000
  end-page: 597
  ident: RF12
  article-title: DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
  publication-title: Cell
– volume: 76
  start-page: 393
  year: 1995
  end-page: 399
  ident: RF6
  article-title: The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus
  publication-title: J. Gen. Virol.
– volume: 193
  start-page: 671
  year: 2001
  end-page: 678
  ident: RF4
  article-title: A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection
  publication-title: J. Exp. Med.
– volume: 124
  start-page: 453
  year: 2001
  end-page: 460
  ident: RF20
  article-title: Early immune responses accompanying human asymptomatic Ebola infections
  publication-title: Clin. Exp. Immunol.
– volume: 147
  start-page: 199
  year: 1985
  end-page: 209
  ident: RF5
  article-title: Ultrastructural pathology of experimental Ebola haemorrhagic fever virus infection
  publication-title: J. Pathol.
– volume: 95
  start-page: 2509
  year: 1998
  end-page: 2514
  ident: RF14
  article-title: A simplified system for generating recombinant adenoviruses
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 76
  start-page: 227
  year: 1995
  end-page: 236
  ident: RF18
  article-title: Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus
  publication-title: Int. J. Exp. Pathol.
– volume: 74
  start-page: 10074
  year: 2000
  end-page: 10080
  ident: RF23
  article-title: Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding
  publication-title: J. Virol.
– volume: 56
  start-page: 271
  year: 1978
  end-page: 293
  ident: RF35
  article-title: Ebola hemorrhagic fever in Zaire, 1976
  publication-title: Bull. World Health Organ.
– volume: 2
  start-page: 299
  year: 1992
  end-page: 312
  ident: RF13
  article-title: Carbohydrate structure of Marburg virus glycoprotein
  publication-title: Glycobiology
– volume: 165
  start-page: 2937
  year: 2000
  end-page: 2942
  ident: RF32
  article-title: DC-SIGN: A related gene, DC-SIGNR, and CD23 form a cluster on 19p13
  publication-title: J. Immunol.
– volume: 72
  start-page: 8463
  year: 1998
  end-page: 8471
  ident: RF9
  article-title: A third-generation lentivirus vector with a conditional packaging system
  publication-title: J. Virol.
– volume: 75
  start-page: 10523
  year: 2001
  end-page: 10526
  ident: RF25
  article-title: DC-SIGN interactions with human immunodeficiency virus: Virus binding and transfer are dissociable functions
  publication-title: J. Virol.
– volume: 76
  start-page: 6841
  year: 2002
  end-page: 6844
  ident: RF1
  article-title: C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans
  publication-title: J. Virol.
– volume: 96
  start-page: 5215
  year: 1999
  end-page: 5220
  ident: RF19
  article-title: Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 179
  start-page: S199
  year: 1999
  end-page: S202
  ident: RF28
  article-title: An analysis of features of pathogenesis in two animal models of Ebola virus infection
  publication-title: J. Infect. Dis.
– volume: 168
  start-page: 421
  year: 1989
  end-page: 425
  ident: RF2
  article-title: Nucleotide sequence of the Lassa virus (Josiah strain) S genome RNA and amino acid sequence comparison of the N and GPC proteins to other arenaviruses
  publication-title: Virology
– volume: 206
  start-page: 935
  year: 1995
  end-page: 944
  ident: RF8
  article-title: Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes
  publication-title: Virology
– volume: 65
  start-page: 561
  year: 2001
  end-page: 566
  ident: RF16
  article-title: Multiplex analysis of cytokines in the blood of cynomolgus macaques naturally infected with Ebola virus (reston serotype)
  publication-title: J. Med. Virol.
– volume: 98
  start-page: 2670
  year: 2001
  end-page: 2675
  ident: RF26
  article-title: DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 76
  start-page: 9135
  year: 2002
  end-page: 9142
  ident: RF3
  article-title: Quantitative expression and virus transmission analysis of DC-SIGN on monocyte-derived dendritic cells
  publication-title: J. Virol.
– volume: 276
  start-page: 28939
  year: 2001
  end-page: 28945
  ident: RF22
  article-title: A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands
  publication-title: J. Biol. Chem.
– volume: 235
  start-page: 117
  year: 1999
  end-page: 143
  ident: RF11
  article-title: Experimental filovirus infections
  publication-title: Curr. Top. Microbiol. Immunol.
– volume: 98
  start-page: 2670
  year: 2001
  ident: 10.1006/viro.2002.1730_RF26
  article-title: DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.051631398
– volume: 75
  start-page: 4664
  year: 2001
  ident: 10.1006/viro.2002.1730_RF24
  article-title: DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus
  publication-title: J. Virol.
  doi: 10.1128/JVI.75.10.4664-4672.2001
– volume: 56
  start-page: 271
  year: 1978
  ident: 10.1006/viro.2002.1730_RF35
  article-title: Ebola hemorrhagic fever in Zaire, 1976
  publication-title: Bull. World Health Organ.
– volume: 7
  start-page: 213
  year: 1977
  ident: 10.1006/viro.2002.1730_RF15
  article-title: Glycosylation of VSV glycoprotein is similar in cystic fibrosis, heterozygous carrier, and normal human fibroblasts
  publication-title: J. Supramol. Struct.
  doi: 10.1002/jss.400070206
– volume: 76
  start-page: 1866
  year: 2002
  ident: 10.1006/viro.2002.1730_RF17
  article-title: Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques
  publication-title: J. Virol.
  doi: 10.1128/JVI.76.4.1866-1875.2002
– volume: 276
  start-page: 28939
  year: 2001
  ident: 10.1006/viro.2002.1730_RF22
  article-title: A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M104565200
– volume: 165
  start-page: 2937
  year: 2000
  ident: 10.1006/viro.2002.1730_RF32
  article-title: DC-SIGN: A related gene, DC-SIGNR, and CD23 form a cluster on 19p13
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.165.6.2937
– volume: 72
  start-page: 8463
  year: 1998
  ident: 10.1006/viro.2002.1730_RF9
  article-title: A third-generation lentivirus vector with a conditional packaging system
  publication-title: J. Virol.
  doi: 10.1128/JVI.72.11.8463-8471.1998
– volume: 235
  start-page: 117
  year: 1999
  ident: 10.1006/viro.2002.1730_RF11
  article-title: Experimental filovirus infections
  publication-title: Curr. Top. Microbiol. Immunol.
– volume: 235
  start-page: 175
  year: 1999
  ident: 10.1006/viro.2002.1730_RF30
  article-title: Molecular pathogenesis of filovirus infections: Role of macrophages and endothelial cells
  publication-title: Curr. Top. Microbiol. Immunol.
– volume: 76
  start-page: 9135
  year: 2002
  ident: 10.1006/viro.2002.1730_RF3
  article-title: Quantitative expression and virus transmission analysis of DC-SIGN on monocyte-derived dendritic cells
  publication-title: J. Virol.
  doi: 10.1128/JVI.76.18.9135-9142.2002
– volume: 100
  start-page: 587
  year: 2000
  ident: 10.1006/viro.2002.1730_RF12
  article-title: DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
  publication-title: Cell
  doi: 10.1016/S0092-8674(00)80694-7
– volume: 76
  start-page: 2518
  year: 2002
  ident: 10.1006/viro.2002.1730_RF31
  article-title: Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence
  publication-title: J. Virol.
  doi: 10.1128/jvi.76.5.2518-2528.2002
– volume: 147
  start-page: 199
  year: 1985
  ident: 10.1006/viro.2002.1730_RF5
  article-title: Ultrastructural pathology of experimental Ebola haemorrhagic fever virus infection
  publication-title: J. Pathol.
  doi: 10.1002/path.1711470308
– volume: 71
  start-page: 445
  year: 2002
  ident: 10.1006/viro.2002.1730_RF33
  article-title: Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro
  publication-title: J. Leukoc. Biol.
  doi: 10.1189/jlb.71.3.445
– volume: 96
  start-page: 5215
  year: 1999
  ident: 10.1006/viro.2002.1730_RF19
  article-title: Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.96.9.5215
– volume: 2
  start-page: 299
  year: 1992
  ident: 10.1006/viro.2002.1730_RF13
  article-title: Carbohydrate structure of Marburg virus glycoprotein
  publication-title: Glycobiology
  doi: 10.1093/glycob/2.4.299
– volume: 76
  start-page: 6841
  year: 2002
  ident: 10.1006/viro.2002.1730_RF1
  article-title: C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans
  publication-title: J. Virol.
  doi: 10.1128/JVI.76.13.6841-6844.2002
– volume: 23
  start-page: 628
  year: 1995
  ident: 10.1006/viro.2002.1730_RF34
  article-title: A transient three-plasmid expression system for the production of high titer retroviral vectors
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/23.4.628
– volume: 246
  start-page: 179
  year: 1998
  ident: 10.1006/viro.2002.1730_RF36
  article-title: A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus
  publication-title: Virology
  doi: 10.1006/viro.1998.9218
– volume: 95
  start-page: 2509
  year: 1998
  ident: 10.1006/viro.2002.1730_RF14
  article-title: A simplified system for generating recombinant adenoviruses
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.95.5.2509
– volume: 179
  start-page: S36
  year: 1999
  ident: 10.1006/viro.2002.1730_RF38
  article-title: A novel immunohistochemical assay for the detection of Ebola virus in skin: Implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. Commission de Lutte contre les Epidemies a Kikwit
  publication-title: J. Infect. Dis.
  doi: 10.1086/514319
– volume: 294
  start-page: 2163
  year: 2001
  ident: 10.1006/viro.2002.1730_RF10
  article-title: Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR
  publication-title: Science
  doi: 10.1126/science.1066371
– volume: 124
  start-page: 453
  year: 2001
  ident: 10.1006/viro.2002.1730_RF20
  article-title: Early immune responses accompanying human asymptomatic Ebola infections
  publication-title: Clin. Exp. Immunol.
  doi: 10.1046/j.1365-2249.2001.01517.x
– volume: 168
  start-page: 421
  year: 1989
  ident: 10.1006/viro.2002.1730_RF2
  article-title: Nucleotide sequence of the Lassa virus (Josiah strain) S genome RNA and amino acid sequence comparison of the N and GPC proteins to other arenaviruses
  publication-title: Virology
  doi: 10.1016/0042-6822(89)90287-0
– volume: 106
  start-page: 117
  year: 2001
  ident: 10.1006/viro.2002.1730_RF7
  article-title: Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses
  publication-title: Cell
  doi: 10.1016/S0092-8674(01)00418-4
– volume: 206
  start-page: 935
  year: 1995
  ident: 10.1006/viro.2002.1730_RF8
  article-title: Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes
  publication-title: Virology
  doi: 10.1006/viro.1995.1016
– volume: 72
  start-page: 3155
  year: 1998
  ident: 10.1006/viro.2002.1730_RF37
  article-title: Characterization of Ebola virus entry by using pseudotyped viruses: Identification of receptor-deficient cell lines
  publication-title: J. Virol.
  doi: 10.1128/JVI.72.4.3155-3160.1998
– volume: 76
  start-page: 227
  year: 1995
  ident: 10.1006/viro.2002.1730_RF18
  article-title: Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus
  publication-title: Int. J. Exp. Pathol.
– volume: 193
  start-page: 671
  year: 2001
  ident: 10.1006/viro.2002.1730_RF4
  article-title: A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.193.6.671
– volume: 68
  start-page: 5133
  year: 1994
  ident: 10.1006/viro.2002.1730_RF21
  article-title: Structural elements in glycoprotein 70 from polytropic Friend mink cell focus-inducing virus and glycoprotein 71 from ecotropic Friend murine leukemia virus, as defined by disulfide-bonding pattern and limited proteolysis
  publication-title: J. Virol.
  doi: 10.1128/jvi.68.8.5133-5141.1994
– volume: 65
  start-page: 561
  year: 2001
  ident: 10.1006/viro.2002.1730_RF16
  article-title: Multiplex analysis of cytokines in the blood of cynomolgus macaques naturally infected with Ebola virus (reston serotype)
  publication-title: J. Med. Virol.
  doi: 10.1002/jmv.2073
– volume: 74
  start-page: 10074
  year: 2000
  ident: 10.1006/viro.2002.1730_RF23
  article-title: Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding
  publication-title: J. Virol.
  doi: 10.1128/JVI.74.21.10074-10080.2000
– volume: 75
  start-page: 10523
  year: 2001
  ident: 10.1006/viro.2002.1730_RF25
  article-title: DC-SIGN interactions with human immunodeficiency virus: Virus binding and transfer are dissociable functions
  publication-title: J. Virol.
  doi: 10.1128/JVI.75.21.10523-10526.2001
– volume: 22
  start-page: 643
  year: 2001
  ident: 10.1006/viro.2002.1730_RF27
  article-title: DC-SIGN and DC-SIGNR: Helping hands for HIV
  publication-title: Trends Immunol.
  doi: 10.1016/S1471-4906(01)02081-6
– volume: 179
  start-page: S199
  year: 1999
  ident: 10.1006/viro.2002.1730_RF28
  article-title: An analysis of features of pathogenesis in two animal models of Ebola virus infection
  publication-title: J. Infect. Dis.
  doi: 10.1086/514293
– volume: 235
  start-page: 145
  year: 1999
  ident: 10.1006/viro.2002.1730_RF29
  article-title: Animal pathology of filoviral infections
  publication-title: Curr. Top. Microbiol. Immunol.
– volume: 76
  start-page: 393
  year: 1995
  ident: 10.1006/viro.2002.1730_RF6
  article-title: The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus
  publication-title: J. Gen. Virol.
  doi: 10.1099/0022-1317-76-2-393
SSID ssj0004770
Score 2.2608912
Snippet Ebola virus exhibits a broad cellular tropism in vitro. In humans and animal models, virus is found in most tissues and organs during the latter stages of...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 115
SubjectTerms Cell Adhesion Molecules - physiology
Ebolavirus - physiology
Endothelium, Vascular - cytology
Endothelium, Vascular - virology
Humans
Lectins, C-Type - physiology
Macrophages - virology
Membrane Glycoproteins - physiology
Receptors, Cell Surface - physiology
Transduction, Genetic
Viral Matrix Proteins - physiology
Title DC-SIGN and DC-SIGNR Bind Ebola Glycoproteins and Enhance Infection of Macrophages and Endothelial Cells
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0042682202917307
https://dx.doi.org/10.1006/viro.2002.1730
https://www.ncbi.nlm.nih.gov/pubmed/12504546
https://www.proquest.com/docview/18631881
https://www.proquest.com/docview/72929056
Volume 305
WOSCitedRecordID wos000180214200012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection Journals 2021
  customDbUrl:
  eissn: 1096-0341
  dateEnd: 20210102
  omitProxy: false
  ssIdentifier: ssj0004770
  issn: 0042-6822
  databaseCode: AIEXJ
  dateStart: 19950110
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9pAEF6RpJV6qfouaZvuoWoPyI3tXXvXx5QSSoRo1ZCIm2Wv1wXJMgQISv5Bf3ZnHzaglj4OvViWmV1g5_PszOw8EHpDpJ8IN_Qd2PoShyZeCu9cFjnC51lOSBYGQnct6bPBgI9G0ZdG43uVC7MqWFnym5to9l9ZDc-A2Sp19h_YXU8KD-AemA5XYDtc_4rxH9vOea87MDHG5v5r6wOY3q1OCnZsq1vciqkuz6CiYxRVpxzrxIGeDcwqTVyMau41TlQNCEOUqWStQnnY27IoFptq7eVkbmo5_aK3z4av4XyilqHq0m5PeqRcGVF1to4-7s6n34xndsONe6n83ToebWy6Q9vEispnQbTPItiUw9R3Qu5vyWGypqgBZ6SqZzI-7QbtmQTln2Q_yA_gjcoO1JEn7z1mT3y2imwPPsenF_1-POyMhm9nV47qP6bO6W0zlj104LMgAvl4cNLrjM7WObaM1elM6pdXBUDd8Hj7K3cpOLsMGK3IDB-g-9YCwScGOQ9RQ5aP0F3Tk_T2MRpbzGBYbVzhByv8YI0fvIUfTWXxg2v84GmON_BjiWr8YI2fJ-jitDNsf3JsOw5HUE6XDslYCtIaZqIuTwRNA9fNWSJ8QiOSZ4wJSgXor66AzzgjUZ6LVBcgTGDt_IQ8RfvltJTPEZZSiiwKKQ85pQERPHVFKqNICgYbngiayKnWMBa2Vr1qmVLEpsp2GKs1Vy1U_ViteRO9q-lnpkrLTsrjiiVxlXsMu2UMINo5wqtHWK3UaJu_HfO64nYM4lqdwSWlnF4vYo-HsItybzcFWLt-BGZJEz0zMFn_I1VuMKDh4R9nf4HurV-7l2h_Ob-Wr9AdsVpOFvMjtMdG_MgC_AdEQcX3
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=DC-SIGN+and+DC-SIGNR+Bind+Ebola+Glycoproteins+and+Enhance+Infection+of+Macrophages+and+Endothelial+Cells&rft.jtitle=Virology+%28New+York%2C+N.Y.%29&rft.au=Simmons%2C+G&rft.au=Reeves%2C+J+D&rft.au=Grogan%2C+C+C&rft.au=Vandenberghe%2C+L+H&rft.date=2003-01-05&rft.issn=0042-6822&rft.volume=305&rft.issue=1&rft.spage=115&rft.epage=123&rft_id=info:doi/10.1006%2Fviro.2002.1730&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0042-6822&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0042-6822&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0042-6822&client=summon